Clinical Trial Detail

NCT ID NCT01898793
Title Cytokine-induced Memory-like NK Cells in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

myelodysplastic syndrome

acute myeloid leukemia

Therapies

Aldesleukin + Cyclophosphamide + Fludarabine

ALT-803 + Cyclophosphamide + Fludarabine

Age Groups: adult senior

No variant requirements are available.